Does cannabis have anti-cancer properties?
In recent years, there has been growing interest in the potential use of cannabis in cancer treatment. Preclinical studies, both in vitro (using cell lines) and in vivo (using animals), suggest that cannabis, and particularly its key components such as cannabinoids (THC, CBD) and terpenes, may have anticancer properties.
Mechanisms of action
Cannabinoids act on CB1 and CB2 receptors in the human body, which are crucial for regulating various biological processes, including cancer cell growth. Studies on brain cancers such as multiform glioblastoma have shown that cannabis terpenes can inhibit cancer cell proliferation and induce apoptosis—the process by which cancer cells are destroyed. Similar effects were observed in studies on breast, lung, colon, and melanoma cancers.
Cannabinoids not only inhibit cancer cell growth but also influence angiogenesis, the formation of new blood vessels, which is crucial for tumor development. Furthermore, research indicates the potential for cannabinoids to synergize with traditional therapies such as chemotherapy, increasing treatment effectiveness and reducing side effects.
Preclinical study results
Most studies have been conducted on animal models, such as mice, and on laboratory-grown cancer cells. Studies on lung cancer and glioblastoma found that cannabinoids reduced the size of tumors in animals and inhibited cancer cell growth. Cannabinoids have also been shown to inhibit the growth of cancer cells in colon cancer and melanoma.
In the context of cancer pain, clinical studies have shown that cannabinoids, particularly CBD, can effectively relieve pain in patients, reducing the need for opioids, which may contribute to improving their quality of life.
The future of research
Despite promising preclinical research results, most of these studies were conducted in animals and cell lines, meaning further human trials are necessary before these therapies can be used in clinical practice. While current research suggests that cannabis may be supportive in cancer therapy, larger-scale clinical trials are needed to assess its effectiveness and safety in the treatment of various types of cancer.
Conclusions
Cannabis has shown promising anticancer properties in preclinical studies. Cannabinoids may inhibit cancer cell growth, complement standard therapies, and alleviate cancer-related pain. While these results are encouraging, further research is needed to fully confirm their potential in human cancer.